You have read all your free articles, to continue reading subscribe to read the rest of this content.
Researchers at Karolinska Institutet and Science for Life Laboratory in Sweden and Tor Vergata University of Rome in Italy have mapped the immune response in children affected by a rare but life-threatening inflammatory syndrome associated with COVID-19. The study, which is published in the scienAlready a subscriber Login You have…
Researchers at Karolinska Institutet have identified metabolic processes that SARS-CoV-2 uses to attack lung tissue. The results, which are published in Molecular & Cellular Proteomics, could be used to treat COVID-19, and potentially for other viruses like the Crimean-Congo hemorrhagic feverAlready a subscriber Login You have read all your free…
Nykode Therapeutics has announced that the first subject has been dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate in its VB-D-01 Phase 1/2 trial. The T cell specific vaccine is designed to prime T cells, potentially generating a broad immune response against current andAlready a subscriber Login You…
Researchers at Karolinska Institutet report promising results from an in vitro combination therapy against COVID-19. In a study published in EMBO Molecular Medicine, the researchers show that a combination of remdesivir, an approved drug against COVID-19, and hrsACE2, a medicine currently in phasAlready a subscriber Login You have read all…
